BioSpace News Archive

BioMidwest

Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at Upcoming Society for Immunotherapy of Cancer Annual Meeting

Navidea Biopharmaceuticals, Inc. today announced that results from the Company’s ongoing preclinical studies evaluating targeted immunotherapy for cancer based on the Manocept platform have been accepted for presentation at the 37th Annual Meeting of the Society for Immunotherapy of Cancer.

October 5, 2022
·
4 min read
Biotech Beach

LadRx Corporation Announces OTCQB Ticker Change to LADX

LadRx Corporation announced it is changing its OTCQB ticker symbol from CYTR to LADX effective Thursday, October 6, 2022.

October 5, 2022
·
2 min read
Business

BIOQUAL, Inc. Announces New CFO

BIOQUAL, Inc., Announces Promotion of Mr. Charles C. Kirk, Jr., CPA. to the Position of Chief Financial Officer.

October 5, 2022
·
1 min read
Genetown

ONWARD Announces Topline Results from the LIFT Home Study Supporting Safety and Feasibility of ARC-EX Therapy to Treat People with Spinal Cord Injury at Home

ONWARD Medical N.V. reported topline results from the LIFT Home study, evaluating the safety and feasibility of ARC-EX Therapy when used at home.

October 5, 2022
·
6 min read
Biotech Beach

SpineX Demonstrates Groundbreaking Technology to Treat Children with Cerebral Palsy

SpineX, Inc., a clinical stage medtech company announced the groundbreaking results its first in human study in children with cerebral palsy.

October 5, 2022
·
3 min read
Prokarium Strengthens Patent Position Through Notice of Allowance of US Patent for Immunotherapy Prime in Combination with Cell Therapies

Prokarium Ltd, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, announced the receipt of a Notice of Allowance from the United States Patent and Trademark Office.

October 5, 2022
·
2 min read
InDex Pharmaceuticals to exhibit at United European Gastroenterology Week

InDex Pharmaceuticals Holding AB announced that the company will be exhibiting at the United European Gastroenterology Week October 8-11, 2022 in Vienna.

October 5, 2022
·
4 min read
BioCapital

I-Mab Announces Poster Presentations of CD47 Antibody Lemzoparlimab and CD73 Antibody Uliledlimab at SITC 2022

I-Mab today announced that the Company will present new preclinical data of its core assets lemzoparlimab and uliledlimab, respectively, at the 37th Society for Immunotherapy of Cancer’s (SITC) Annual Meeting in Boston, MA, as well as virtually November 8-12, 2022.

October 5, 2022
·
5 min read
Biotech Bay

Eiger BioPharmaceuticals Provides Update on Plans for Emergency Use Authorization Application Following FDA Feedback

Eiger BioPharmaceuticals, Inc. today announced that, following feedback from the U.S. Food and Drug Administration (FDA), the company will not submit an emergency use authorization (EUA) application of peginterferon lambda for the treatment of patients with mild-to-moderate COVID-19.

October 5, 2022
·
7 min read
AbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022

AbCellera (Nasdaq: ABCL) today announced a presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, to be held virtually and at the Boston Convention & Exhibition Center from November 8 to 12, 2022.

October 5, 2022
·
3 min read